Chiron Real Estate Inc. (NYSE: XRN) is a Real Estate company (REIT - Healthcare Facilities) with a market capitalization of $342M. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Chiron Real Estate Inc. had a Maz Rating of 4.74 out of 5 (A, Strong Buy), ranked against the other companies in its sector. Its strongest factor then was Valuation (4.47), more attractively valued than most of its sector; its weakest was Momentum (3.70), above most of its sector. The other factors: Growth 4.12 (above most of its sector); Profitability 3.92 (above most of its sector); Financial Health 3.89 (above most of its sector). The current rating is for members: log in to see it.
At $25.80, Chiron Real Estate Inc. trades at 7.0x trailing earnings, 2.2x sales and 0.5x book value, with an EV/EBITDA of 6.4. Over the last twelve months it generated about $157M of revenue and $49M of net income. It runs a gross margin of -4.5%, an operating margin of 19.4% and a net margin of 36.6%. It shows return on equity of 9.9%, return on invested capital of 3.7% and a free cash flow yield of -61.2%. On the balance sheet: a debt-to-equity ratio of 1.03 and a current ratio of 59.65. Over the past 52 weeks the share price ranged from $25.70 to $38.65, with a beta of 1.13.
Chiron Real Estate Inc. pays a dividend yielding 8.92%, with 75% of earnings paid out.
5 Wall Street analyst ratings cover the stock: 2 Buy and 3 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Chiron Real Estate Inc. (XRN) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 300.1% / 30% · (Cash+Inv) / Mkt Cap (36m) 298.8% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 300.1% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 3.05% / 33% · Receivables / Mkt Cap (36m) 2.70% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 300.1% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 3.05% / 33.33% · Receivables / Mkt Cap (24m) 2.70% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 62.4% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 0.85% / 33.33% · Receivables / Avg Assets (4Q) 0.63% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 94.5% / 33.33% · (Cash+ST Inv) / Total Assets 0.96% / 33.33% · (Cash+Recv) / Total Assets 1.81% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, Chiron Real Estate Inc. (XRN) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Chiron Real Estate Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m) and (Cash+Inv) / Mkt Cap (36m).
Chiron Real Estate Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.